Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias
Breithardt, G.; Seipel, L.; Lersmacher, J.; Abendroth, R.R.
Journal of Cardiovascular Pharmacology 4(2): 276-284
1982
ISSN/ISBN: 0160-2446
PMID: 6175812
DOI: 10.1097/00005344-198203000-00017
Accession: 042616327
PDF emailed within 0-6 h: $19.90
Related References
Van Durme, J.P. 1980: Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias Acta Cardiologica. Supplementum 25: 121-125Ricciardelli, B.; Volpe, M.; De Luca, N.; D'Ascia, C.; Bonaduce, D.; Trimarco, B.; Rengo, F.; Condorelli, M. 1981: Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine Bollettino Della Societa Italiana di Cardiologia 26(2): 139-144
Strano, A.; Novo, S.; Davi, G.; Alaimo, G.; Immordino, R.; Cutietta, A. 1987: Effects of mexiletine r and disopyramide r on ventricular arrhythmias in patients with chronic ischemic heart disease European Heart Journal 8(ABSTR Suppl 2): 194
Ohashi, K.; Ebihara, A.; Hashimoto, T.; Hosoda, S.; Kondo, K.; Oka, T. 1984: Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias Arzneimittel-Forschung 34(4): 503-507
Breithardt, G.; Seipel, L.; Abendroth, R.R. 1981: Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia Journal of Cardiovascular Pharmacology 3(5): 1026-1037
Komori, S.; Sano, S.; Li, B.H.; Matsumura, K.; Naitoh, A.; Mochizuki, S.; Ishihara, T.; Watanabe, A.; Umetani, K.; Ijiri, H. 1995: Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide Heart and Vessels 10(1): 7-11
Komori, S.; Sawanobori, T.; Tamura, K.; Kane, K.A.; Parratt, J.R. 1994: Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine Japanese Journal of Pharmacology 65(3): 193-200
Widerhorn, J.; Bhandari, A.K.; Sager, P.T.; Amico, N.; Rahimtoola, S.H. 1989: Lack of efficacy of combination therapy with mexiletine and class ia antiarrhythmic drugs in patients with inducible sustained ventricular arrhythmias refractory to intravenous procainamide Clinical Research 37(1): 102A
Menozzi, C.; Lolli, G.; Monducci, I.; Gheller, G.; Brignole, M.; Cattabiani, M.L.; Vergoni, W.; Barone, A. 1984: Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects La Clinica Terapeutica 108(3): 199-208
Awaji, T.; Hashimoto, K. 1993: Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias Journal of Cardiovascular Pharmacology 21(6): 960-966
Whitford, E.G.; McGovern, B.; Schoenfeld, M.H.; Garan, H.; Newell, J.B.; McElroy, M.; Ruskin, J.N. 1988: Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias American Heart Journal 115(2): 360-366
Tanabe, T.; Takahashi, K.; Yoshioka, K.; Goto, Y. 1991: Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease International Journal of Cardiology 32(3): 303-312
Klempt, H.W.; Nayebagha, A.; Fabry, E. 1982: Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. a comparative study in patients after myocardial infarction Zeitschrift für Kardiologie 71(5): 340-349
Jewitt, D.E.; Jackson, G.; McComish, M. 1977: Comparative anti-arrhythmic efficacy of mexiletine, procainamide and tolamolol in patients with symptomatic ventricular arrhythmias Postgraduate Medical Journal 53(Suppl): 158-162
Kim, S.G.; Mercando, A.D.; Fisher, J.D. 1987: Combination of disopyramide and mexiletine for additive efficacy for ventricular arrhythmias without additive side effects Circulation 76(4 Part 2): IV512